CSIMarket
 


Fennec Pharmaceuticals Inc   (FENCF)
Other Ticker:  
 
 

Fennec Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Fennec Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 5.12, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Fennec Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 71 days, compared to 79 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 204 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 0 to 1755.

What is Receivable Turnover Ratio?
What is Fennec Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




FENCF Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) 5.12 4.61 3.98 3.97 -
FENCF's Total Ranking # 1755 # 0 # 0 # 0 # 0
Average receivable collection period 71 79 92 92 -
Seq. Receivable Change 85.07 % 45.28 % 8.93 % - -
Seq. Revenue Change 95.94 % 98.27 % 9.25 % - -


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 11
Healthcare Sector # 205
Overall Market # 1755

Receivable Turnover Ratio Statistics
High Average Low
0.6 0.6 0.6
(Sep 30 2023)  






Financial Statements
Fennec Pharmaceuticals Inc 's Accounts Receivable $ 5 Millions Visit FENCF's Balance sheet
Fennec Pharmaceuticals Inc 's Sales TTM $ 13 Millions Visit FENCF's Income Statement
Where are FENCF's Sales coming from? Visit FENCF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FENCF's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for FENCF's Competitors
Receivables Turnover Ratio for FENCF's Suppliers
Accounts Receivables Turnover Ratio for FENCF's Customers

You may also want to know
FENCF's Growth Rates FENCF's Roa FENCF's Inventory Turnover Ratio FENCF's Dividend Comparisons
FENCF's Profitability Ratios FENCF's Roi FENCF's Asset Turnover Ratio FENCF's Dividend Growth
FENCF's Valuation Ratios FENCF's Roe FENCF's Financial Strength Ratios FENCF's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Escalon Medical Corp   7.86 $ 11.990  Millions$ 1.525  Millions
Encompass Health Corporation  7.83 $ 4,149.400  Millions$ 529.875  Millions
Clearside Biomedical Inc   7.78 $ 2.211  Millions$ 0.284  Millions
Akebia Therapeutics Inc   7.73 $ 193.611  Millions$ 25.057  Millions
Avinger Inc   7.67 $ 7.318  Millions$ 0.954  Millions
Nephros Inc   7.67 $ 12.015  Millions$ 1.567  Millions
Singular Genomics Systems Inc   7.64 $ 2.595  Millions$ 0.340  Millions
Shockwave Medical Inc   7.64 $ 670.271  Millions$ 87.764  Millions
Exelixis Inc   7.64 $ 1,774.473  Millions$ 232.410  Millions
Akili Inc   7.60 $ 1.170  Millions$ 0.154  Millions
Malachite Innovations Inc   7.60 $ 14.363  Millions$ 1.891  Millions
Strata Skin Sciences Inc   7.59 $ 33.441  Millions$ 4.404  Millions
Inari Medical Inc   7.59 $ 468.832  Millions$ 61.763  Millions
Lemaitre Vascular Inc   7.57 $ 184.930  Millions$ 24.423  Millions
Encision Inc   7.56 $ 6.970  Millions$ 0.922  Millions
Alpha Teknova Inc   7.55 $ 35.550  Millions$ 4.709  Millions
Star Equity Holdings Inc   7.55 $ 77.173  Millions$ 10.224  Millions
Omniab Inc   7.55 $ 88.419  Millions$ 11.714  Millions
Fate Therapeutics Inc   7.54 $ 106.213  Millions$ 14.088  Millions
Axonics Inc   7.53 $ 341.566  Millions$ 45.349  Millions
Edwards Lifesciences Corporation  7.51 $ 5,818.600  Millions$ 774.350  Millions
Amedisys Inc   7.49 $ 2,227.658  Millions$ 297.318  Millions
Quest Diagnostics Inc  7.49 $ 9,297.000  Millions$ 1,241.250  Millions
Delcath Systems Inc   7.49 $ 2.164  Millions$ 0.289  Millions
Atrion Corporation  7.46 $ 168.597  Millions$ 22.590  Millions
Igc Pharma Inc   7.46 $ 1.343  Millions$ 0.180  Millions
Ginkgo Bioworks Holdings Inc   7.44 $ 314.985  Millions$ 42.363  Millions
Alpha Pro Tech Ltd   7.40 $ 58.166  Millions$ 7.856  Millions
Amneal Pharmaceuticals Inc   7.38 $ 2,379.687  Millions$ 322.458  Millions
T2 Biosystems Inc   7.36 $ 10.997  Millions$ 1.494  Millions

Date modified: 2023-11-12T05:50:09+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com